NPPB and pulmonary arterial hypertension: Finally, up to 10% of PAH cases have been shown to be linked with mutations in activin-like receptor kinase 1, endoglin, SMAD family member 9, and caveolin-1 genes, encoding for ligands involved in colocalization of BNP receptors, and downstream activation of BNP signaling pathway [39,43,44].